$ASNS
ACTELIS NETWORKS INC Stock $asns

$asns Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022046937 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$1.348M	$3.081M	$1.870M
YoY Change	-5.2%	1.78%	20.65%
Cost Of Revenue	$813.0K	$1.159M	$1.290M
YoY Change	-9.26%	-10.02%	57.7%
Gross Profit	$535.0K	$1.922M	$582.0K
YoY Change	1.71%	10.52%	-20.05%
Gross Profit Margin	39.69%	62.38%	31.12%
Selling, General & Admin	$1.818M	$1.904M	$1.360M
YoY Change	106.12%	119.61%	85.54%
% of Gross Profit	339.81%	99.06%	233.68%
Research & Development	$723.0K	$676.0K	$650.0K
YoY Change	30.98%	4.64%	4.84%
% of Gross Profit	135.14%	35.17%	111.68%
Depreciation & Amortization	$9.000K	$10.00K	-$2.000K
YoY Change			-116.67%
% of Gross Profit	1.68%	0.52%	-0.34%
Operating Expenses	$2.541M	$2.580M	$2.117M
YoY Change	77.2%	70.52%	50.57%
Operating Profit	-$2.006M	-$658.0K	-$1.535M
YoY Change	120.93%	-391.15%	126.4%
Interest Expense	-$201.0K	-$996.0K	$107.0K
YoY Change			98.15%
% of Operating Profit
Other Income/Expense, Net	-$201.0K	-$996.0K	-$3.210M
YoY Change	-27.96%	284.56%	-6044.44%
Pretax Income	-$2.207M	-$1.654M	-$4.640M
YoY Change			583.36%
Income Tax
% Of Pretax Income
Net Earnings	-$2.207M	-$1.654M	-$4.639M
YoY Change	85.93%	4912.12%	583.21%
Net Earnings / Revenue	-163.72%	-53.68%	-248.07%
Basic Earnings Per Share	-$0.13	-$0.17	-$22.60
Diluted Earnings Per Share	-$0.13	-$0.17	-$2.263M
COMMON SHARES
Basic Shares Outstanding	17.32M shares	9.523M shares	205.2K shares
Diluted Shares Outstanding	17.32M shares	9.523M shares	205.2K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.27M	$12.36M	$606.0K
YoY Change
Cash & Equivalents	$10.21M	$12.29M	$344.0K
Short-Term Investments	$68.00K	$71.00K	$262.0K
Other Short-Term Assets	$1.299M	$1.903M	$1.045M
YoY Change
Inventory	$1.062M	$908.0K	$931.0K
Prepaid Expenses
Receivables	$2.110M	$3.109M	$1.330M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.75M	$18.28M	$3.920M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$108.0K	$99.00K	$976.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.472M	$1.183M	$436.0K
YoY Change
Total Long-Term Assets	$1.580M	$1.282M	$1.410M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$14.75M	$18.28M	$3.920M
Total Long-Term Assets	$1.580M	$1.282M	$1.410M
Total Assets	$16.33M	$19.56M	$5.330M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$853.0K	$1.659M	$1.540M
YoY Change
Accrued Expenses	$2.134M	$2.022M	$2.590M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$777.0K	$768.0K	$7.270M
YoY Change
Total Short-Term Liabilities	$5.591M	$6.477M	$12.19M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$4.374M	$4.564M	$8.080M
YoY Change
Other Long-Term Liabilities	$52.00K	$61.00K	-$8.170M
YoY Change
Total Long-Term Liabilities	$5.171M	$5.325M	-$90.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.591M	$6.477M	$12.19M
Total Long-Term Liabilities	$5.171M	$5.325M	-$90.00K
Total Liabilities	$10.76M	$11.80M	$23.96M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$30.92M	-$28.71M
YoY Change
Common Stock	$1.000K	$1.000K	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.563M	$7.757M	-$24.22M
YoY Change
Total Liabilities & Shareholders Equity	$16.33M	$19.56M	$5.330M
YoY Change

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.207M	-$1.654M	-$4.639M
YoY Change	85.93%	4912.12%	583.21%
Depreciation, Depletion And Amortization	$9.000K	$10.00K	-$2.000K
YoY Change			-116.67%
Cash From Operating Activities	-$1.994M	-$2.475M	-$504.0K
YoY Change			-37.24%
INVESTING ACTIVITIES
Capital Expenditures	-$18.00K	-$1.000K	-$13.00K
YoY Change			550.0%
Acquisitions
YoY Change
Other Investing Activities	$3.000K	$191.0K	-$262.0K
YoY Change
Cash From Investing Activities	-$15.00K	$190.0K	-$275.0K
YoY Change			13650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$129.0K
YoY Change
Cash From Financing Activities	-193.0K	14.50M	-272.0K
YoY Change			-113.67%
NET CHANGE
Cash From Operating Activities	-1.994M	-2.475M	-504.0K
Cash From Investing Activities	-15.00K	190.0K	-275.0K
Cash From Financing Activities	-193.0K	14.50M	-272.0K
Net Change In Cash	-2.202M	12.22M	-1.051M
YoY Change			-188.69%
FREE CASH FLOW
Cash From Operating Activities	-$1.994M	-$2.475M	-$504.0K
Capital Expenditures	-$18.00K	-$1.000K	-$13.00K
Free Cash Flow	-$1.976M	-$2.474M	-$491.0K
YoY Change			-38.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Revenues Revenues	4573000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1159000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41375
	dei	Entity Registrant Name EntityRegistrantName	ACTELIS NETWORKS, INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
	dei	City Area Code CityAreaCode	(510)
	dei	Local Phone Number LocalPhoneNumber	545-1045
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	ASNS
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17317572	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12286000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	71000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	770000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61000	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3109000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2147000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	908000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	897000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1133000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	398000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18277000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4135000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	91000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	102000	usd
CY2022Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	234000	usd
CY2021Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	266000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	776000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	82000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	78000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1282000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	549000	usd
CY2022Q2	us-gaap	Assets Assets	19559000	usd
CY2021Q4	us-gaap	Assets Assets	4684000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	768000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	758000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	74000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1659000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1920000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	669000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	673000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	780000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	703000	usd
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	968000	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	818000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	505000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1054000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	902000	usd
	asns	Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate	0.25	pure
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6477000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5951000	usd
CY2022Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4564000	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	5473000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	231000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1972000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4905000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	190000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	279000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	315000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	79000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5325000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12744000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	11802000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	18695000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	5585000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11009315	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17317572	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17317572	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2047641	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2047641	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1783773	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1783773	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36469000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2824000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28713000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22420000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7757000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19559000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4684000	usd
CY2022Q2	us-gaap	Revenues Revenues	3081000	usd
CY2021Q2	us-gaap	Revenues Revenues	3027000	usd
	us-gaap	Revenues Revenues	4949000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1288000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2445000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2106000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1922000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1739000	usd
	us-gaap	Gross Profit GrossProfit	2504000	usd
	us-gaap	Gross Profit GrossProfit	2467000	usd
CY2022Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	676000	usd
CY2021Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	646000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1326000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1266000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	837000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	538000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1567000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	949000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1067000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	329000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1702000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	651000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2580000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1513000	usd
	us-gaap	Operating Expenses OperatingExpenses	4595000	usd
	us-gaap	Operating Expenses OperatingExpenses	2866000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-658000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	226000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2091000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-399000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-996000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-259000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4202000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1654000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-33000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6293000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-712000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9522719	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047641	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5787503	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047641	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-14398000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-679000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-15067000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-33000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-15092000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4639000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-24221000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2022Q2	asns	Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock Upon Initial Public Offering StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering	5585000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	14675000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6553000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3600000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3190000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1654000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7757000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6293000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-712000	usd
	us-gaap	Depreciation Depreciation	20000	usd
	us-gaap	Depreciation Depreciation	23000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1115000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	80000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	55000	usd
	asns	Exchange Rate Differences ExchangeRateDifferences	-739000	usd
	asns	Exchange Rate Differences ExchangeRateDifferences	-37000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18000	usd
	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	962000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1240000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	82000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	91000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-18000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	735000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	525000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-18000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-261000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-45000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	227000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	573000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	225000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	270000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	136000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	112000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	153000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-77000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3782000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1549000	usd
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41375
	dei	Entity Registrant Name EntityRegistrantName	ACTELIS NETWORKS, INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
	dei	City Area Code CityAreaCode	(510)
	dei	Local Phone Number LocalPhoneNumber	545-1045
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	ASNS
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17317572	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12286000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	71000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	770000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61000	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3109000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2147000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	908000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	897000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1133000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	398000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18277000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4135000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	91000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	102000	usd
CY2022Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	234000	usd
CY2021Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	266000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	776000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	82000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	78000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1282000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	549000	usd
CY2022Q2	us-gaap	Assets Assets	19559000	usd
CY2021Q4	us-gaap	Assets Assets	4684000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	768000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	758000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	74000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1659000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1920000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	669000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	673000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	780000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	703000	usd
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	968000	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	818000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-71000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2070000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18712000	usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	2175000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	316000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	192000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16221000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1878000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-739000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-37000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12352000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	327000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	671000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13147000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	998000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12286000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	898000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	770000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	91000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	100000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13147000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	998000	usd
	us-gaap	Interest Paid Net InterestPaidNet	377000	usd
	us-gaap	Interest Paid Net InterestPaidNet	261000	usd
CY2022Q2	asns	Underwriter Option To Purchase UnderwriterOptionToPurchase	462500	shares
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	1400000	usd
CY2021Q4	us-gaap	Shares Issued SharesIssued	900096	shares
CY2022Q2	us-gaap	Shares Issued SharesIssued	180000	shares
	us-gaap	Partners Capital Account Units Redeemed PartnersCapitalAccountUnitsRedeemed	1783773	shares
	asns	Warrants Exercisable WarrantsExercisable	294875	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	at any time during a period of 5 years from the issuance date (i.e. until May 17, 2027).
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1054000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	902000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6477000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	505000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td><td><b>Use of estimates in preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, Fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company's management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.95in; text-align: justify; text-indent: 0in"> </p>
CY2021Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	106000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	204000	usd
CY2022Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	158000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	262000	usd
CY2022Q2	asns	Right Of Use Asset RightOfUseAsset	1046000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5951000	usd
CY2022Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4564000	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	5473000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	231000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1972000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4905000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	190000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	279000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	315000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	79000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5325000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12744000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	11802000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	18695000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	5585000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11009315	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17317572	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17317572	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2047641	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2047641	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1783773	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1783773	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36469000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2824000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28713000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22420000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7757000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19559000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4684000	usd
CY2022Q2	us-gaap	Revenues Revenues	3081000	usd
CY2021Q2	us-gaap	Revenues Revenues	3027000	usd
	us-gaap	Revenues Revenues	4949000	usd
	us-gaap	Revenues Revenues	4573000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1159000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1288000	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1450000	usd
CY2021Q4	us-gaap	Other Notes Payable OtherNotesPayable	4905000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	2149000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">i)</span></td><td style="text-align: justify"><b>Concentration of risk</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The Company has major customers, representing:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">47% and 0% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">19% and 47% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">14% and 21% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The Company does not see any credit risk regarding this debt, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">See note 11 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p>
	us-gaap	Cost Of Revenue CostOfRevenue	2445000	usd
CY2021	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.208	pure
CY2020Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	550000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	356000	usd
CY2020Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	358000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	541000	usd
CY2020Q2	us-gaap	Inventory Gross InventoryGross	908000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	897000	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	80000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	55000	usd
	asns	Convertible Note Offering Amount ConvertibleNoteOfferingAmount	3000000	usd
	asns	Convertible Note Offering Percentage ConvertibleNoteOfferingPercentage	0.06	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
	asns	Convertible Note Description ConvertibleNoteDescription	The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance.
CY2022Q2	us-gaap	Public Utilities Requested Rate Increase Decrease Percentage PublicUtilitiesRequestedRateIncreaseDecreasePercentage	0.25	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58	pure
CY2022Q2	asns	Risk Free Rate Percentage RiskFreeRatePercentage	0.0241	pure
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y2M1D
	asns	Addition Addition	1847000	usd
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1753000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3600000	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	678000	usd
	us-gaap	Other Expenses OtherExpenses	1753000	usd
	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.75	pure
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
CY2022Q1	us-gaap	Additional Liability Long Duration Insurance Current Weighted Average Discount Rate AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate	0.40	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.772	pure
CY2021	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.772	pure
	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.214	pure
	us-gaap	Cost Of Revenue CostOfRevenue	2106000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1922000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1739000	usd
	us-gaap	Gross Profit GrossProfit	2504000	usd
	us-gaap	Gross Profit GrossProfit	2467000	usd
CY2022Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	676000	usd
CY2021Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	646000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1326000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1266000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	837000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	538000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1567000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	949000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1067000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	329000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1702000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	651000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2580000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1513000	usd
	us-gaap	Operating Expenses OperatingExpenses	4595000	usd
	us-gaap	Operating Expenses OperatingExpenses	2866000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-658000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	226000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2091000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-399000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-996000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-259000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4202000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1654000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-33000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6293000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-712000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9522719	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047641	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5787503	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047641	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-14398000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-679000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-15067000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-33000	usd
CY2021	asns	Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate	0.625	pure
	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P2Y9M
CY2021	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P3Y
	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	26500000	usd
CY2021	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	24300000	usd
	asns	Volatility Percentages VolatilityPercentages	0.58	pure
CY2021	asns	Volatility Percentages VolatilityPercentages	0.58	pure
	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0241	pure
CY2021	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0097	pure
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4905000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3563000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1648000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1342000	usd
	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	6553000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	4905000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	682000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1648000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
CY2016Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	73048	shares
	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.75	pure
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
	asns	Private Holding Percenatge PrivateHoldingPercenatge	0.25	pure
CY2021	asns	Private Holding Percenatge PrivateHoldingPercenatge	0.625	pure
	asns	Volatility Percentage VolatilityPercentage	0.58	pure
CY2021	asns	Volatility Percentage VolatilityPercentage	0.58	pure
	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0241	pure
CY2021	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0097	pure
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y2M1D
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y4M24D
	asns	Ipo Scenario Expected Term IPOScenarioExpectedTerm	P2Y9M
CY2021	asns	Ipo Scenario Expected Term IPOScenarioExpectedTerm	P3Y
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2020Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	1023000	usd
	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	1115000	usd
CY2021	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	1031000	usd
CY2021	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	95000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3190000	usd
CY2022Q2	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	74000	usd
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2022Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	57000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1115000	usd
CY2021Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
CY2022Q2	us-gaap	Lease Income LeaseIncome	41000	usd
	us-gaap	Lease Income LeaseIncome	81000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	776000	usd
CY2022Q2	asns	Current Operating Lease Liabilities CurrentOperatingLeaseLiabilities	505000	usd
CY2022Q2	asns	Non Current Operating Lease Liabilities NonCurrentOperatingLeaseLiabilities	190000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	695000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	270000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M13D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.025	pure
	us-gaap	Operating Lease Cost OperatingLeaseCost	262000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	104000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	8000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5000	usd
	us-gaap	Lease Cost LeaseCost	270000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	109000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	283000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	364000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-15092000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4639000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-24221000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2022Q2	asns	Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock Upon Initial Public Offering StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering	5585000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	14675000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6553000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3600000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3190000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1654000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7757000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6293000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-712000	usd
	us-gaap	Depreciation Depreciation	20000	usd
	us-gaap	Depreciation Depreciation	23000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1115000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	80000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	55000	usd
	asns	Exchange Rate Differences ExchangeRateDifferences	-739000	usd
	asns	Exchange Rate Differences ExchangeRateDifferences	-37000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18000	usd
	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	962000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1240000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	82000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	91000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-18000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	735000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	525000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-18000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-261000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-45000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	227000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	573000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	225000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	270000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	136000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	112000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	153000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-77000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	867012	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	82000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	729000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	34000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	695000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	516000	usd
	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2022Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	14300000	usd
CY2022Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	15500000	usd
CY2022Q2	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10000000	usd
CY2022Q2	us-gaap	Servicing Liability ServicingLiability	968000	usd
CY2021Q4	us-gaap	Servicing Liability ServicingLiability	818000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890493	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	15460	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8021	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.61
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y7M13D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	812611	shares
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	103000	usd
	asns	Revenues Percentage RevenuesPercentage	0.10	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.08
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M9D
CY2022Q2	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	867012	shares
CY2021Q2	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	856493	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.121
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.088
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	7731043	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3081000	usd
CY2021Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3027000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	4949000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	4573000	usd
CY2022Q2	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	673000	usd
CY2021Q4	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	581000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-241000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-452000	usd
CY2022Q2	asns	Additions Additions	468000	usd
CY2021Q4	asns	Additions Additions	544000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	900000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	673000	usd
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	99000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3782000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1549000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-71000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2070000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18712000	usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	2175000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	316000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	192000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16221000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1878000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-739000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-37000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12352000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	327000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	671000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13147000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	998000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12286000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	898000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	770000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	91000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	100000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13147000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	998000	usd
	us-gaap	Interest Paid Net InterestPaidNet	377000	usd
	us-gaap	Interest Paid Net InterestPaidNet	261000	usd
CY2022Q2	asns	Underwriter Option To Purchase UnderwriterOptionToPurchase	462500	shares
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	1400000	usd
CY2021Q4	us-gaap	Shares Issued SharesIssued	900096	shares
CY2022Q2	us-gaap	Shares Issued SharesIssued	180000	shares
	us-gaap	Partners Capital Account Units Redeemed PartnersCapitalAccountUnitsRedeemed	1783773	shares
	asns	Warrants Exercisable WarrantsExercisable	294875	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	at any time during a period of 5 years from the issuance date (i.e. until May 17, 2027).
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2015Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	106000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Number Of Shares Of Equity Securities Issued By Employer And Related Parties Included In Plan Assets DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets	27699	shares
CY2022Q2	asns	Related Party Transactions Purchases From Related Party RelatedPartyTransactionsPurchasesFromRelatedParty	4.55
CY2022Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	126000	usd
CY2015Q1	asns	Related Party Fair Value Price Per Share RelatedPartyFairValuePricePerShare	0.55
CY2015Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5000	usd
	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	150000	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	4000000	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	100000	usd
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	50000	usd
CY2022Q1	asns	Aggregate Amount aggregateAmount	100000	usd
CY2022Q1	us-gaap	Collateralized Agreements CollateralizedAgreements	150000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	asns	Common Stock Value1 CommonStockValue1		usd
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td><td><b>Use of estimates in preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, Fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company's management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.95in; text-align: justify; text-indent: 0in"> </p>
CY2021Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	106000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	204000	usd
CY2022Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	158000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	262000	usd
CY2022Q2	asns	Right Of Use Asset RightOfUseAsset	1046000	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1450000	usd
CY2021Q4	us-gaap	Other Notes Payable OtherNotesPayable	4905000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	2149000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">i)</span></td><td style="text-align: justify"><b>Concentration of risk</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The Company has major customers, representing:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">47% and 0% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">19% and 47% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">14% and 21% of the Company Trade receivables balance as of June 30, 2022 and December 31, 2021 respectively.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The Company does not see any credit risk regarding this debt, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">See note 11 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"> </p>
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2020Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	550000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	356000	usd
CY2020Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	358000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	541000	usd
CY2020Q2	us-gaap	Inventory Gross InventoryGross	908000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	897000	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	80000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	55000	usd
	asns	Convertible Note Offering Amount ConvertibleNoteOfferingAmount	3000000	usd
	asns	Convertible Note Offering Percentage ConvertibleNoteOfferingPercentage	0.06	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
	asns	Convertible Note Description ConvertibleNoteDescription	The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance.
CY2022Q2	us-gaap	Public Utilities Requested Rate Increase Decrease Percentage PublicUtilitiesRequestedRateIncreaseDecreasePercentage	0.25	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58	pure
CY2022Q2	asns	Risk Free Rate Percentage RiskFreeRatePercentage	0.0241	pure
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y2M1D
	asns	Addition Addition	1847000	usd
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1753000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3600000	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	678000	usd
	us-gaap	Other Expenses OtherExpenses	1753000	usd
	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.75	pure
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
CY2022Q1	us-gaap	Additional Liability Long Duration Insurance Current Weighted Average Discount Rate AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate	0.40	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.772	pure
CY2021	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.772	pure
	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.214	pure
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent		usd
CY2022Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent		usd
CY2021	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease		usd
	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions		usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001141284
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2021	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.208	pure
	asns	Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate	0.25	pure
CY2021	asns	Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate	0.625	pure
	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P2Y9M
CY2021	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	P3Y
	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	26500000	usd
CY2021	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	24300000	usd
	asns	Volatility Percentages VolatilityPercentages	0.58	pure
CY2021	asns	Volatility Percentages VolatilityPercentages	0.58	pure
	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0241	pure
CY2021	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0097	pure
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4905000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3563000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1648000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1342000	usd
	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	6553000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	4905000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	682000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1648000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	0	usd
CY2016Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	73048	shares
	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.75	pure
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
	asns	Private Holding Percenatge PrivateHoldingPercenatge	0.25	pure
CY2021	asns	Private Holding Percenatge PrivateHoldingPercenatge	0.625	pure
	asns	Volatility Percentage VolatilityPercentage	0.58	pure
CY2021	asns	Volatility Percentage VolatilityPercentage	0.58	pure
	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0241	pure
CY2021	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0097	pure
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y2M1D
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y4M24D
	asns	Ipo Scenario Expected Term IPOScenarioExpectedTerm	P2Y9M
CY2021	asns	Ipo Scenario Expected Term IPOScenarioExpectedTerm	P3Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M9D
CY2020Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	1023000	usd
	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	1115000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	729000	usd
CY2021	us-gaap	Servicing Liability At Fair Value Other Changes In Fair Value ServicingLiabilityAtFairValueOtherChangesInFairValue	1031000	usd
CY2021	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	95000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3190000	usd
CY2022Q2	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	74000	usd
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2022Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	57000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1115000	usd
CY2021Q2	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
CY2022Q2	us-gaap	Lease Income LeaseIncome	41000	usd
	us-gaap	Lease Income LeaseIncome	81000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	776000	usd
CY2022Q2	asns	Current Operating Lease Liabilities CurrentOperatingLeaseLiabilities	505000	usd
CY2022Q2	asns	Non Current Operating Lease Liabilities NonCurrentOperatingLeaseLiabilities	190000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	695000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	270000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M13D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.025	pure
	us-gaap	Operating Lease Cost OperatingLeaseCost	262000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	104000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	8000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5000	usd
	us-gaap	Lease Cost LeaseCost	270000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	109000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	283000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	364000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	82000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	34000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	695000	usd
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y7M13D
CY2021Q4	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	516000	usd
	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2022Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	14300000	usd
CY2022Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	15500000	usd
CY2022Q2	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10000000	usd
CY2022Q2	us-gaap	Servicing Liability ServicingLiability	968000	usd
CY2021Q4	us-gaap	Servicing Liability ServicingLiability	818000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890493	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	15460	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8021	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.61
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	867012	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	812611	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.08
CY2022Q2	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	867012	shares
CY2021Q2	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	856493	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.121
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.088
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	7731043	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3081000	usd
CY2021Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3027000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	4949000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	4573000	usd
CY2022Q2	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	673000	usd
CY2021Q4	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	581000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-241000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-452000	usd
CY2022Q2	asns	Additions Additions	468000	usd
CY2021Q4	asns	Additions Additions	544000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	900000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	673000	usd
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	99000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	103000	usd
	asns	Revenues Percentage RevenuesPercentage	0.10	pure
CY2015Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	106000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Number Of Shares Of Equity Securities Issued By Employer And Related Parties Included In Plan Assets DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets	27699	shares
CY2022Q2	asns	Related Party Transactions Purchases From Related Party RelatedPartyTransactionsPurchasesFromRelatedParty	4.55
CY2022Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	126000	usd
CY2015Q1	asns	Related Party Fair Value Price Per Share RelatedPartyFairValuePricePerShare	0.55
CY2015Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5000	usd
	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	150000	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	4000000	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	100000	usd
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	50000	usd
CY2022Q1	asns	Aggregate Amount aggregateAmount	100000	usd
CY2022Q1	us-gaap	Collateralized Agreements CollateralizedAgreements	150000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001141284

Files In Submission

Name	View Source	Status
0001213900-22-046937-index-headers.html	Edgar Link	pending
0001213900-22-046937-index.html	Edgar Link	pending
0001213900-22-046937.txt	Edgar Link	pending
0001213900-22-046937-xbrl.zip	Edgar Link	pending
asns-20220630.xsd	Edgar Link	pending
f10q0622ex31-1_actelisnet.htm	Edgar Link	pending
f10q0622ex31-2_actelisnet.htm	Edgar Link	pending
f10q0622ex32-1_actelisnet.htm	Edgar Link	pending
f10q0622ex32-2_actelisnet.htm	Edgar Link	pending
f10q0622_actelisnet.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
asns-20220630_cal.xml	Edgar Link	unprocessable
asns-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
asns-20220630_lab.xml	Edgar Link	unprocessable
f10q0622_actelisnet_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
asns-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASNS
ACTELIS NETWORKS INC Stock $asns

2022 Q3 Form 10-Q Financial Statement

#000121390022046937 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS ACTELIS NETWORKS INC Stock $asns

2022 Q3 Form 10-Q Financial Statement

#000121390022046937 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS
ACTELIS NETWORKS INC Stock $asns